Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GN Store Nord ASGGNDF 74 Debt-to-EBITDA is 2.07 as of Mar. 2026, which is 25% below its 10-year median of 2.76. GuruFocus rates GGNDF with a GF Score™ of 74/100 and a GF Value™ of $15.89 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 469 Medical Devices & Instruments companies, GN Store Nord AS ranks worse than 71.43% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for GN Store Nord AS's Debt-to-EBITDA or its related term are showing as below:
GGNDF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.62 Med: 2.76 Max: 6.65
Current: 3.14
During the past 13 years, the highest Debt-to-EBITDA Ratio of GN Store Nord AS was 6.65. The lowest was 1.62. And the median was 2.76.
GGNDF's Debt-to-EBITDA is ranked worse than 71.43% of 469
companies
in the Medical Devices & Instruments industry
Industry Median: 1.6
vs GGNDF: 3.14
GN Store Nord AS (OTCPK:GGNDF) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
GN Store Nord AS Debt-to-EBITDA Related Terms
GN Store Nord AS Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for GN Store Nord AS's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, GN Store Nord AS's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GN Store Nord AS Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GN Store Nord AS's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where GN Store Nord AS's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
GN Store Nord AS (GGNDF) has a Debt-to-EBITDA of 2.07 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on GN Store Nord AS. This is 25% below median its historical median of 2.76. Over the past decade, GN Store Nord AS's Debt-to-EBITDA has ranged from 1.62 to 6.65. According to the industry distribution chart, GN Store Nord AS ranks #335 out of 469 companies in the Medical Devices & Instruments industry, placing it in the top 71.4%.
Is GN Store Nord AS's Debt-to-EBITDA too high?
GN Store Nord AS's current Debt-to-EBITDA of 2.07 is 25% below median its 10-year median of 2.76. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 6.65. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.60. GN Store Nord AS's value of 2.07 is 29.4% above this industry median. Based on the distribution chart, GN Store Nord AS ranks #335 out of 469 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, GN Store Nord AS has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GN Store Nord AS's Debt-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, GN Store Nord AS ranks #335 out of 469 companies for Debt-to-EBITDA. This places GN Store Nord AS in the lower half of its industry. The industry median Debt-to-EBITDA is 1.60. GN Store Nord AS's value of 2.07 is 29.4% above this benchmark. Historically, GN Store Nord AS's own Debt-to-EBITDA has ranged from 1.62 to 6.65 over the past decade. While the company's 10-year median is 2.76 vs. the industry median of 1.60, GN Store Nord AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.60, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GN Store Nord AS's current Debt-to-EBITDA of 2.07 is 29.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on GN Store Nord AS. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GN Store Nord AS's current Debt-to-EBITDA is 2.07, which is 25% below median its own 10-year median of 2.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GN Store Nord AS stock overvalued right now?
Based on GuruFocus' analysis, GN Store Nord AS (GGNDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $15.89, compared to a current price of $13.39 — trading 15.8% below its estimated fair value. The current Debt-to-EBITDA is 2.07, which is 25% below median its 10-year median of 2.76 and 29.4% above the Medical Devices & Instruments industry median of 1.60. GN Store Nord AS's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For GN Store Nord AS (GGNDF), the current Debt-to-EBITDA is 2.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GN Store Nord AS (GGNDF) Overvalued in 2026?
Based on GuruFocus' analysis, GN Store Nord AS stock appears to be undervalued.
The current stock price of $13.39 is trading 15.8% below its estimated GF Value™ of $15.89.
GuruFocus considers GN Store Nord AS to be Modestly Undervalued.
Key valuation signals for GGNDF:
Debt-to-EBITDA: 2.07 (25% below median its 10-year median of 2.76)
GF Value™: $15.89 vs. price of $13.39 (15.8% below fair value)
Industry Position: 29.4% above the Medical Devices & Instruments median (#335 of 469)
No single metric tells the full story. See the GGNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
74GF Score
Get the complete analysis for GGNDF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GGNDF has been successfully added to your 
